细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV103
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID SU-CCS-1
AC CVCL_B470
SY Su-ccs-1; Su CCS-1; SU-CCS1
DR ATCC; CRL-2971
DR Cosmic; 1092866
RX PubMed=6362860;
RX PubMed=7753552;
RX PubMed=12966428;
RX PubMed=15150091;
RX PubMed=16766266;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 12,14
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-1
AC CVCL_0538
SY SUDHL1; SUDHL-1; SuDHL 1; Stanford University-Diffuse Histiocytic Lymphoma-1
DR BTO; BTO:0005058
DR CLO; CLO_0009160
DR EFO; EFO_0005461
DR MCCL; MCC:0000439
DR ATCC; CRL-2955
DR BioSample; SAMN03471710
DR CCLE; SUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308303
DR ChEMBL-Targets; CHEMBL2366200
DR Cosmic; 909742
DR Cosmic; 946364
DR Cosmic; 1086003
DR Cosmic; 1086367
DR Cosmic; 1086753
DR Cosmic; 1152235
DR Cosmic; 1995646
DR Cosmic; 2361379
DR Cosmic-CLP; 909742
DR DSMZ; ACC-356
DR GDSC; 909742
DR GEO; GSM887652
DR GEO; GSM888744
DR GEO; GSM1217155
DR GEO; GSM1670482
RX PubMed=83902;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=2525056;
RX PubMed=3881165;
RX PubMed=4140017;
RX PubMed=8547074;
RX PubMed=9738977;
RX PubMed=11021758;
RX PubMed=11494142;
RX PubMed=15356658;
RX PubMed=16596703;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; COG; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,13
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 12,16
ST D21S11: 29,30
ST D2S1338: 19,20
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,13
ST D8S1179: 11
ST FGA: 21
ST Penta D: 14
ST Penta E: 11,15
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-10
AC CVCL_1889
SY SUDHL10; Sudhl10; SUDHL-10; SuDHL 10; Stanford University-Diffuse Histiocytic Lymphoma-10; DHL10
DR EFO; EFO_0002354
DR ATCC; CRL-2963
DR BioSample; SAMN03471872
DR CCLE; SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 850207
DR Cosmic; 1067460
DR Cosmic; 1079257
DR Cosmic; 1517644
DR Cosmic; 1541914
DR Cosmic; 1636685
DR Cosmic; 2276343
DR Cosmic; 2361377
DR Cosmic-CLP; 1331033
DR DSMZ; ACC-576
DR GDSC; 1331033
DR GEO; GSM380143
DR GEO; GSM552468
DR GEO; GSM887651
DR GEO; GSM888743
DR GEO; GSM1059808
DR GEO; GSM1374904
DR GEO; GSM1670483
DR IGRhCellID; SUDHL10
RX PubMed=83902;
RX PubMed=177185;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=1465024;
RX PubMed=3881165;
RX PubMed=9738977;
RX PubMed=8547074;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~15-30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 10,11
ST D16S539: 10,11
ST D18S51: 17
ST D21S11: 31
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 8
ST FGA: 22,23
ST Penta D: 9,11
ST Penta E: 16,17
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-11
AC CVCL_W958
SY SUDHL11; Stanford University-Diffuse Histiocytic Lymphoma-11; DHL-11
RX PubMed=83902;
RX PubMed=3881165;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-12
AC CVCL_W959
SY SUDHL12; Stanford University-Diffuse Histiocytic Lymphoma-12; DHL-12
RX PubMed=83902;
RX PubMed=3881165;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-13
AC CVCL_H736
SY SUDHL13; Stanford University-Diffuse Histiocytic Lymphoma-13; DHL-13
RX PubMed=3881165;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-14
AC CVCL_W960
SY SUDHL14; Stanford University-Diffuse Histiocytic Lymphoma-14; DHL-14
RX PubMed=3881165;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-15
AC CVCL_W961
SY SUDHL15; Stanford University-Diffuse Histiocytic Lymphoma-15; DHL-15
RX PubMed=3881165;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-16
AC CVCL_1890
SY SUDHL16; SUDHL-16; Stanford University-Diffuse Histiocytic Lymphoma-16; DHL-16
DR EFO; EFO_0002355
DR ATCC; CRL-2964
DR BioSample; SAMN03472751
DR Cosmic; 1070713
DR Cosmic-CLP; 1331034
DR DSMZ; ACC-577
DR GDSC; 1331034
DR GEO; GSM380144
DR GEO; GSM1670484
DR IGRhCellID; SUDHL16
DR IZSLER; BS TCL 226
RX PubMed=19278952;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Peritoneal effusion.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 11,13
ST D18S51: 12,13
ST D21S11: 30,31
ST D3S1358: 14
ST D5S818: 10
ST D7S820: 9,10
ST D8S1179: 12
ST FGA: 20,21
ST Penta D: 10,13
ST Penta E: 13
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-18
AC CVCL_9551
SY SUDHL-18; Stanford University-Diffuse Histiocytic Lymphoma-18
DR Cosmic; 1295513
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SU-DHL-2
AC CVCL_9550
SY SUDHL2; SUDHL-2; Su-DHL-2; SU-DHL2; SuDHL 2; Stanford University-Diffuse Histiocytic Lymphoma-2; DHL-2
DR EFO; EFO_0007611
DR ATCC; CRL-2956
DR Cosmic; 1289989
DR Cosmic; 1486588
DR Cosmic; 1517653
DR Cosmic; 1550339
DR Cosmic; 1636686
DR Cosmic; 2361374
DR GEO; GSM1374905
RX PubMed=83902;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=4140017;
RX PubMed=8547074;
RX PubMed=15356658;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Peritoneal effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 14
ST D5S818: 13
ST D7S820: 11,13
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-3
AC CVCL_W769
SY SU-DHL-3 (clone 1); Stanford University-Diffuse Histiocytic Lymphoma-3; DHL-3
RX PubMed=83902;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=4140017;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-4
AC CVCL_0539
SY SUDHL4; Sudhl4; SUDHL-4; SuDHL 4; SUD4; SUD-4; SU4; Stanford University-Diffuse Histiocytic Lymphoma-4; DHL-4; DHL4
DR BTO; BTO:0004076
DR EFO; EFO_0006492
DR MCCL; MCC:0000440
DR ATCC; CRL-2957
DR BioSample; SAMN03473232
DR CCLE; SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308053
DR ChEMBL-Targets; CHEMBL613711
DR Cosmic; 850203
DR Cosmic; 932763
DR Cosmic; 999780
DR Cosmic; 1067443
DR Cosmic; 1079254
DR Cosmic; 1517656
DR Cosmic; 1541909
DR Cosmic; 1636687
DR Cosmic; 1714160
DR Cosmic; 1945192
DR Cosmic; 2276338
DR Cosmic; 2361375
DR Cosmic; 2437313
DR Cosmic-CLP; 1331035
DR DSMZ; ACC-495
DR GDSC; 1331035
DR GEO; GSM380145
DR GEO; GSM499735
DR GEO; GSM552463
DR GEO; GSM887653
DR GEO; GSM888745
DR GEO; GSM1374906
DR GEO; GSM1670485
DR ICLC; HTL10002
DR Lonza; 270
DR PRIDE; PXD000589
RX PubMed=83902;
RX PubMed=177185;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=2875799;
RX PubMed=3881165;
RX PubMed=8547074;
RX PubMed=9738977;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=23292937;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Cell surface proteome.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Discontinued: ICLC; HTL10002; true.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 14,16
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 19,21
ST Penta D: 9,14
ST Penta E: 7,11
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-5
AC CVCL_1735
SY SUDHL5; SUDHL-5; SU-DH-L5; SuDHL 5; Stanford University-Diffuse Histiocytic Lymphoma-5; DHL-5; DHL5
DR EFO; EFO_0002356
DR ATCC; CRL-2958
DR BioSample; SAMN03472762
DR CCLE; SUDHL5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 850204
DR Cosmic; 1079255
DR Cosmic; 1517657
DR Cosmic; 1541910
DR Cosmic; 2276339
DR Cosmic; 2361380
DR Cosmic; 2437314
DR Cosmic-CLP; 1331036
DR DSMZ; ACC-571
DR GDSC; 1331036
DR GEO; GSM1962
DR GEO; GSM380146
DR GEO; GSM552464
DR GEO; GSM887654
DR GEO; GSM888746
DR GEO; GSM1151287
DR GEO; GSM1374907
DR GEO; GSM1670486
DR IGRhCellID; SUDHL5
RX PubMed=83902;
RX PubMed=177185;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=8547074;
RX PubMed=10676951;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 13,15
ST D21S11: 28,30
ST D3S1358: 15,16
ST D5S818: 12,15
ST D7S820: 10
ST D8S1179: 13,15
ST FGA: 22,23
ST Penta D: 11,12
ST Penta E: 5,19
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-6
AC CVCL_2206
SY SUDHL6; SuDHL6; SU-DHL6; SUDHL-6; SuDHL-6; SUD6; Stanford University-Diffuse Histiocytic Lymphoma-6; DHL-6; DHL6
DR EFO; EFO_0002357
DR ATCC; CRL-2959
DR BioSample; SAMN03471138
DR CCLE; SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 687854
DR Cosmic; 850205
DR Cosmic; 1070712
DR Cosmic; 1329089
DR Cosmic; 1517640
DR Cosmic; 1541911
DR Cosmic; 1629935
DR Cosmic; 1636688
DR Cosmic; 1714158
DR Cosmic; 2276340
DR Cosmic; 2297009
DR Cosmic; 2437315
DR Cosmic-CLP; 1331037
DR DSMZ; ACC-572
DR ENCODE; ENCBS107PVI
DR ENCODE; ENCBS136LHJ
DR ENCODE; ENCBS401ZBX
DR GDSC; 1331037
DR GEO; GSM1955
DR GEO; GSM115975
DR GEO; GSM201348
DR GEO; GSM380147
DR GEO; GSM552465
DR GEO; GSM887655
DR GEO; GSM888747
DR GEO; GSM1374908
DR GEO; GSM1670487
DR IGRhCellID; SUDHL6
DR Lonza; 455
DR PRIDE; PXD000589
RX PubMed=83902;
RX PubMed=177185;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=7849311;
RX PubMed=9738977;
RX PubMed=10676951;
RX PubMed=16960149;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=23699601;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=4672
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~35-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Cell surface proteome.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Derived from metastatic site: Peritoneal cavity.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,14
ST D16S539: 11,12
ST D18S51: 12,13
ST D21S11: 29
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 14
ST FGA: 20,24
ST Penta D: 8,10
ST Penta E: 5,12
ST TH01: 6,9.3
ST TPOX: 11,12
ST vWA: 14,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-7
AC CVCL_4380
SY SUDHL7; SUDHL-7; SuDHL 7; Stanford University-Diffuse Histiocytic Lymphoma-7; DHL-7; DHL7
DR Cosmic; 850206
DR Cosmic; 1290018
DR Cosmic; 1517608
DR Cosmic; 1541912
DR Cosmic; 1945193
DR Cosmic; 2276341
DR Cosmic; 2361373
DR GEO; GSM380148
DR GEO; GSM552466
RX PubMed=83902;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=8547074;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=23292937;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: miRNA expression profiling.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DHL-8
AC CVCL_2207
SY SUDHL8; SUDHL-8; SuDHL 8; Stanford University-Diffuse Histiocytic Lymphoma-8; DHL-8; DHL8
DR EFO; EFO_0006493
DR ATCC; CRL-2961
DR BioSample; SAMN03471060
DR CCLE; SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1067442
DR Cosmic; 1079256
DR Cosmic; 1295511
DR Cosmic; 1517639
DR Cosmic; 1541913
DR Cosmic; 1636689
DR Cosmic; 2276342
DR Cosmic; 2361381
DR Cosmic; 2437316
DR Cosmic-CLP; 1331038
DR DSMZ; ACC-573
DR GDSC; 1331038
DR GEO; GSM380149
DR GEO; GSM552467
DR GEO; GSM887656
DR GEO; GSM888748
DR GEO; GSM1374909
DR GEO; GSM1670488
RX PubMed=83902;
RX PubMed=177185;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=8547074;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~48-72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Derived from metastatic site: Peritoneal effusion.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 12
ST D18S51: 14,19
ST D21S11: 30,31.2
ST D3S1358: 14,15
ST D5S818: 11,13
ST D7S820: 8
ST D8S1179: 13
ST FGA: 25
ST Penta D: 11,12
ST Penta E: 14,17
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DHL-9
AC CVCL_4379
SY SUDHL9; SUDHL-9; SuDHL 9; Stanford University-Diffuse Histiocytic Lymphoma-9; DHL-9; DHL9
DR BTO; BTO:0001617
DR Cosmic; 2361382
DR GEO; GSM380150
RX PubMed=83902;
RX PubMed=177185;
RX PubMed=214220;
RX PubMed=371794;
RX PubMed=3881165;
RX PubMed=8547074;
RX PubMed=9738977;
RX PubMed=19278952;
RX PubMed=23699601;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Genome sequenced.
CC Omics: miRNA expression profiling.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DIPG-IV
AC CVCL_IT39
SY SUDIPGIV; SUDIPG4
RX PubMed=25939062;
CC Characteristics: Has a HIST1H3B p.Lys28Met mutation (H3.1K27M).
CC Omics: Deep RNAseq analysis.
ST Source(s): PubMed=25939062
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 7,12
ST D16S539: 9,12
ST D21S11: 29,31
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DIPG-VI
AC CVCL_IT40
SY SUDIPGVI; DIPG-6
RX PubMed=24777482;
RX PubMed=25939062;
WW http://mckennaclairefoundation.org/
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Omics: Deep RNAseq analysis.
CC Miscellaneous: Established from a sample taken just after the death at age 7 of McKenna Wetzel. When McKenna died, the Wetzels donated to researchers at Stanford University the tissues that allowed this cell line to be derived. They also created the McKenna Claire Foundation's whose mission is to help cure pediatric brain cancer by raising awareness, increasing community involvement and funding research.
ST Source(s): PubMed=25939062
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 8,13
ST D21S11: 29,31
ST D5S818: 10,12
ST D7S820: 8,9
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DIPG-XIII
AC CVCL_IT41
SY SU DIPG XIII; SU-DIPGXIII
RX PubMed=25939062;
RX PubMed=26115193;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
ST Source(s): PubMed=25939062
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 11,12
ST D16S539: 11,12
ST D21S11: 30
ST D5S818: 12
ST D7S820: 9
ST TH01: 6,7
ST TPOX: 8
ST vWA: 13,18
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DUL-1
AC CVCL_IV41
SY Stanford University-Diffuse Undifferentiated Lymphoma-1
RX PubMed=83902;
RX PubMed=6804087;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-DUL-2
AC CVCL_IV42
SY Stanford University-Diffuse Undifferentiated Lymphoma-2
RX PubMed=83902;
RX PubMed=6804087;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU-DUL-3
AC CVCL_IV43
SY Stanford University-Diffuse Undifferentiated Lymphoma-3
RX PubMed=83902;
RX PubMed=6804087;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU-LB-1
AC CVCL_IV34
SY Stanford University-LymphoBlastoid-1
RX PubMed=83902;
RX PubMed=4140017;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SU-LB-2
AC CVCL_IV35
SY Stanford University-LymphoBlastoid-2
RX PubMed=83902;
RX PubMed=174098;
RX PubMed=214220;
RX PubMed=371794;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SU-LB-3
AC CVCL_IV36
SY Stanford University-LymphoBlastoid-3
RX PubMed=83902;
RX PubMed=214220;
RX PubMed=371794;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SU-LB-4
AC CVCL_IV37
SY Stanford University-LymphoBlastoid-4
RX PubMed=83902;
RX PubMed=174098;
RX PubMed=214220;
RX PubMed=371794;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SU-LB-5
AC CVCL_IV38
SY Stanford University-LymphoBlastoid-5
RX PubMed=83902;
RX PubMed=174098;
RX PubMed=214220;
RX PubMed=371794;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SU-pcGBM-2
AC CVCL_IT42
SY SU-pcGBM2
RX PubMed=25939062;
ST Source(s): PubMed=25939062
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,11
ST D21S11: 28,30.2
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU/RH-HD-1
AC CVCL_M692
SY SU/RH-HD1
RX PubMed=2690233;
RX PubMed=6332936;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SU.86.86
AC CVCL_3881
SY SU 86.86; SU-86-86; Su-86-86; SU86.86; SU86-86; SU86_86; Su86_86; SU8686; SU.86
DR BTO; BTO:0001904
DR CLO; CLO_0009150
DR EFO; EFO_0006494
DR ATCC; CRL-1837
DR BioSample; SAMN03472014
DR CCLE; SU8686_PANCREAS
DR CGH-DB; 183-1
DR CGH-DB; 9282-4
DR Cosmic; 707252
DR Cosmic; 868244
DR Cosmic; 873003
DR Cosmic; 913314
DR Cosmic; 922250
DR Cosmic; 923172
DR Cosmic; 932522
DR Cosmic; 949237
DR Cosmic; 1006362
DR Cosmic; 1066203
DR Cosmic; 1122349
DR Cosmic; 1218879
DR Cosmic; 1358486
DR Cosmic; 1518237
DR Cosmic; 1644315
DR Cosmic; 1995645
DR Cosmic; 2434090
DR Cosmic-CLP; 1240218
DR GDSC; 1240218
DR GEO; GSM206545
DR GEO; GSM621901
DR GEO; GSM784693
DR GEO; GSM887650
DR GEO; GSM888742
DR GEO; GSM1024414
DR GEO; GSM1374903
DR GEO; GSM1670481
DR IZSLER; BS TCL 180
DR PRIDE; PXD003198
DR SKY/M-FISH/CGH; 2000
RX PubMed=3264833;
RX PubMed=10027410;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SU.86.86
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 48 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'Su_86_96' in Cosmic 913314.
CC Misspelling: 'SU-88-86' in Cosmic 873003.
CC Derived from metastatic site: Liver.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 9
ST D21S11: 30
ST D3S1358: 14,19
ST D5S818: 7,13
ST D7S820: 8,11
ST D8S1179: 12,15
ST FGA: 21,22
ST Penta D: 9,13
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SU511
AC CVCL_W082
SY Su511
DR Cosmic; 1522784
DR GEO; GSM726284
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SU706A
AC CVCL_S719
DR SKY/M-FISH/CGH; 3861
DI NCIt; C6339; Uterine corpus sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Sua1.1
AC CVCL_Z626
DR BTO; BTO:0002635
RX PubMed=12626708;
CC Group: Insect cell line.
CC Breed/subspecies: Suakoko 2La.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Sua1B
AC CVCL_Z627
SY SuaB.1
RX PubMed=9326640;
RX PubMed=23382679;
RX PubMed=23891577;
WW http://kafatos.openwetware.org/Instructions_for_Anopheles_gambiae_cell_lines.html
CC Group: Insect cell line.
CC Breed/subspecies: Suakoko 2La.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Sua4.0
AC CVCL_Z629
SY Sua 4.0; Suakoko 4
RX PubMed=10681436;
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-921.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-sua-40-cell-line-avcl
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-921.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Suakoko 2La.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Sua5.1*
AC CVCL_Z630
SY Sua 5.1*; Sua 5.1
RX PubMed=10681436;
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-922.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-sua-51-cell-line-avcl
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-922.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Suakoko 2La.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SuaE.1
AC CVCL_Z628
SY SuaE1; SuaE
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-924.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-suae1-cell-line-avcl
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-924.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Suakoko 2La.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Subclone 707 BUF
AC CVCL_4309
DR CLO; CLO_0009151
DR CLDB; cl4411
DR ECACC; 91112122
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP1
AC CVCL_8918
SY 707 DAP1
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP10
AC CVCL_8919
SY 707 DAP10
DR CLO; CLO_0001466
DR CLDB; cl121
DR ECACC; 91112130
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112130; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP2
AC CVCL_8920
SY 707 DAP2
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP3
AC CVCL_8921
SY 707 DAP3
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP4
AC CVCL_8922
SY 707 DAP4; 707DAP4
RX PubMed=3116422;
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP5
AC CVCL_8923
SY 707 DAP5
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP6
AC CVCL_8924
SY 707 DAP6
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP7
AC CVCL_8925
SY 707 DAP7
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP8
AC CVCL_4310
SY 707 DAP8
DR CLO; CLO_0009152
DR CLDB; cl4412
DR ECACC; 91112129
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DAP9
AC CVCL_4Y34
SY 707 DAP9
RX PubMed=3477692;
CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DK 4.8
AC CVCL_8291
DR CLO; CLO_0009153
DR CLDB; cl4413
DR ECACC; 91112119
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112119; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DKA
AC CVCL_8292
DR CLO; CLO_0009154
DR CLDB; cl4414
DR ECACC; 91112117
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112117; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DKE
AC CVCL_8293
DR CLO; CLO_0009155
DR CLDB; cl4415
DR ECACC; 91112132
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112132; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DKH
AC CVCL_8294
DR CLO; CLO_0009156
DR CLDB; cl4416
DR ECACC; 91112131
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112131; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 DKJ
AC CVCL_8295
DR CLO; CLO_0009157
DR CLDB; cl4417
DR ECACC; 91112118
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112118; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 TG1
AC CVCL_8296
DR CLO; CLO_0009158
DR CLDB; cl4418
DR ECACC; 91112127
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112127; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID Subclone 707 TG2
AC CVCL_8297
DR CLO; CLO_0009159
DR CLDB; cl4419
DR ECACC; 91112128
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 91112128; probable.
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID SUBL
AC CVCL_M554
RX PubMed=7506636;
CC Doubling time: ~48 hours (PubMed=7506636).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUHC-1
AC CVCL_HE76
SY Shinshu University Hepatocellular Carcinoma-1
RX PubMed=1328123;
RX PubMed=8280838;
RX PubMed=9737568;
CC Characteristics: Altough established from a patient suffering from persistent HCC infection, HCV-RNA is not detected.
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~24 hours (PubMed=1328123).
DI NCIt; C3098; Hepatitis C infection
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUIT-2
AC CVCL_3172
SY Suit-2; SUIT 2; SUIT2
DR BTO; BTO:0003493
DR EFO; EFO_0006495
DR BioSample; SAMN03472902
DR CCLE; SUIT2_PANCREAS
DR Cosmic; 710872
DR Cosmic; 755300
DR Cosmic; 808161
DR Cosmic; 918051
DR Cosmic; 1108340
DR Cosmic; 1320464
DR Cosmic; 1534322
DR Cosmic; 1995647
DR Cosmic-CLP; 1240219
DR GDSC; 1240219
DR GEO; GSM244426
DR GEO; GSM244427
DR GEO; GSM827218
DR GEO; GSM887657
DR GEO; GSM888749
DR GEO; GSM1588615
DR GEO; GSM1670489
DR JCRB; JCRB1094
DR TKG; TKG 0705
RX PubMed=3102439;
RX PubMed=11169959;
RX PubMed=11787853;
RX PubMed=12800145;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/SUIT-2.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 9
ST D18S51: 16
ST D21S11: 29,30
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 14,15
ST FGA: 20,23
ST Penta D: 11
ST Penta E: 10
ST TH01: 6
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUIT-4
AC CVCL_9280
RX PubMed=15452375;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUIT-58
AC CVCL_1Y17
RX PubMed=26141632;
CC Doubling time: 32 hours (PubMed=26141632).
CC Derived from metastatic site: Liver.
ST Source(s): PubMed=26141632
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 9,11
ST D21S11: 31
ST D5S818: 10,12
ST D7S820: 11,12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Sulubo
AC CVCL_IU22
RX PubMed=4122458;
RX PubMed=4364259;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SUM102PT
AC CVCL_3421
SY SUM-102PT; SUM 102PT; SUM-102; SUM 102; SUM102; Sum102; 102PT
DR BTO; BTO:0005387
DR Cosmic; 904388
DR Cosmic; 997922
DR Cosmic; 1046939
DR Cosmic; 1287928
DR Cosmic; 1289410
DR GEO; GSM217598
DR GEO; GSM350537
DR GEO; GSM1008914
DR GEO; GSM1215255
DR GEO; GSM1401675
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=15677628;
RX PubMed=19582160;
RX PubMed=23601657;
RX PubMed=24162158;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Omics: CNV analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM1315MO2
AC CVCL_5589
SY SUM1315M02; SUM1315-MO2; SUM-1315M02; SUM 1315M02; SUM-1315; SUM 1315; SUM1315; 1315M02
DR BTO; BTO:0005933
DR EFO; EFO_0001239
DR BioSample; SAMN03471829
DR Cosmic; 904394
DR Cosmic; 997924
DR Cosmic; 1046961
DR Cosmic; 1287925
DR Cosmic; 1289417
DR Cosmic; 1460228
DR GEO; GSM217599
DR GEO; GSM1008915
DR GEO; GSM1214566
DR GEO; GSM1374910
DR LINCS; 51081
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
CC Part of: KuDOS 95 cell line panel.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Skin.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 12
ST D21S11: 28,29
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 8,12
ST D8S1179: 13,15
ST FGA: 25
ST Penta D: 13,15
ST Penta E: 5
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM149-Luc
AC CVCL_DH44
DR GEO; GSM1463862
RX PubMed=20229045;
RX PubMed=25279830;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4001; Inflammatory breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3422 ! SUM149PT
SX Female
CA Cancer cell line
//
ID SUM149-Luc/MA1
AC CVCL_DH45
SY MA1
DR GEO; GSM1463860
DR GEO; GSM1463863
RX PubMed=25279830;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4001; Inflammatory breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH44 ! SUM149-Luc
SX Female
CA Cancer cell line
//
ID SUM149-Luc/MA2
AC CVCL_DH46
SY MA2
DR GEO; GSM1463861
DR GEO; GSM1463864
RX PubMed=25279830;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4001; Inflammatory breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH44 ! SUM149-Luc
SX Female
CA Cancer cell line
//
ID SUM149PT
AC CVCL_3422
SY SUM-149PT; SUM 149PT; SUM149; SUM-149; SUM 149; 149 PT; 149PT
DR BTO; BTO:0005475
DR EFO; EFO_0001240
DR BioSample; SAMN03472959
DR Cosmic; 1044208
DR Cosmic; 1046959
DR Cosmic; 1136379
DR Cosmic; 1176631
DR Cosmic; 1287929
DR Cosmic; 1289411
DR Cosmic; 1460239
DR Cosmic; 1523966
DR Cosmic; 1603224
DR Cosmic; 2036674
DR GEO; GSM115105
DR GEO; GSM217600
DR GEO; GSM350549
DR GEO; GSM481335
DR GEO; GSM501233
DR GEO; GSM501234
DR GEO; GSM501235
DR GEO; GSM501237
DR GEO; GSM501238
DR GEO; GSM847433
DR GEO; GSM847500
DR GEO; GSM844705
DR GEO; GSM1008916
DR GEO; GSM1214568
DR GEO; GSM1215280
DR GEO; GSM1374911
DR GEO; GSM1401669
DR LINCS; 51082
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=12353263;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=15857504;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=26495931;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Part of: KuDOS 95 cell line panel.
CC Omics: CNV analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14,15
ST D21S11: 28,31.2
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 14,16
ST FGA: 29
ST Penta D: 8,9
ST Penta E: 11
ST TH01: 9.3
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C4001; Inflammatory breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM159PT
AC CVCL_5423
AS CVCL_5590
SY SUM-159PT; SUM 159PT; SUM-159; SUM 159; SUM159; 159 PT; 159PT
DR BTO; BTO:0004928
DR EFO; EFO_0001241
DR BioSample; SAMN03472960
DR Cosmic; 904389
DR Cosmic; 1046944
DR Cosmic; 1136380
DR Cosmic; 1287924
DR Cosmic; 1289412
DR Cosmic; 1460240
DR GEO; GSM75170
DR GEO; GSM217601
DR GEO; GSM412074
DR GEO; GSM412089
DR GEO; GSM412092
DR GEO; GSM412105
DR GEO; GSM412114
DR GEO; GSM412117
DR GEO; GSM474278
DR GEO; GSM474279
DR GEO; GSM476481
DR GEO; GSM476482
DR GEO; GSM476483
DR GEO; GSM478318
DR GEO; GSM478319
DR GEO; GSM478323
DR GEO; GSM478324
DR GEO; GSM847434
DR GEO; GSM847501
DR GEO; GSM844707
DR GEO; GSM844706
DR GEO; GSM967817
DR GEO; GSM967822
DR GEO; GSM1008917
DR GEO; GSM1214567
DR GEO; GSM1401652
DR LINCS; 51083
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=11044355;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/SUM-159.html
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Microsatellite instability: Stable (MSS) (PubMed=15677628).
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'SUM152'.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12,14
ST D21S11: 28
ST D3S1358: 11,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 11,13
ST FGA: 21,22
ST Penta D: 9,11
ST Penta E: 17
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C5161; Pleomorphic breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM16LN
AC CVCL_Y469
SY SUM-16LN
RX PubMed=8018955;
RX PubMed=8425198;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SUM185PE
AC CVCL_5591
SY SUM-185PE; SUM 185PE; SUM-185; SUM 185; SUM185; 185PE
DR BTO; BTO:0005476
DR EFO; EFO_0001242
DR Cosmic; 904390
DR Cosmic; 1046940
DR Cosmic; 1136381
DR Cosmic; 1176642
DR Cosmic; 1287898
DR Cosmic; 1289413
DR Cosmic; 1460241
DR GEO; GSM847435
DR GEO; GSM847502
DR GEO; GSM844708
DR LINCS; 51084
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=23601657;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM190PT
AC CVCL_3423
SY SUM-190PT; SUM 190PT; SUM-190; SUM 190; SUM190; 190PT
DR BTO; BTO:0005477
DR EFO; EFO_0001243
DR BioSample; SAMN03471033
DR Cosmic; 904391
DR Cosmic; 1046941
DR Cosmic; 1287899
DR Cosmic; 1289414
DR Cosmic; 1460244
DR Cosmic; 1603225
DR GEO; GSM217602
DR GEO; GSM350534
DR GEO; GSM847436
DR GEO; GSM847503
DR GEO; GSM1008918
DR GEO; GSM1215269
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=28196595;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: CNV analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 12
ST D21S11: 28,30
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 10,15
ST FGA: 22
ST Penta D: 10,11
ST Penta E: 18,19
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C4001; Inflammatory breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM206CWN
AC CVCL_5592
SY SUM-206CWN; SUM-206cwn; SUM206; SUM-206
RX PubMed=10424408;
RX PubMed=10604729;
WW http://web.archive.org/web/20040421014855/http://www.cancer.med.umich.edu/breast_cell/Production/sumlines/SUM-206CWN.html
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID SUM225CWN
AC CVCL_5593
SY SUM-225CWN; SUM-225cwn; SUM 225CWN; SUM-225; SUM 225; SUM225; Sum225; 225CWN
DR BTO; BTO:0005478
DR EFO; EFO_0001244
DR Cosmic; 904392
DR Cosmic; 1046960
DR Cosmic; 1136359
DR Cosmic; 1287900
DR Cosmic; 1289415
DR Cosmic; 1460242
DR GEO; GSM320177
DR GEO; GSM847437
DR GEO; GSM847504
DR GEO; GSM844709
DR GEO; GSM844710
DR LINCS; 51085
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=23601657;
RX PubMed=28196595;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM229PE
AC CVCL_5594
SY SUM-229PE; SUM 229PE; SUM-229; SUM 229; SUM229; 229PE
DR BTO; BTO:0005479
DR EFO; EFO_0006762
DR BioSample; SAMN03471035
DR Cosmic; 904393
DR Cosmic; 997923
DR Cosmic; 1046949
DR Cosmic; 1287930
DR Cosmic; 1289416
DR Cosmic; 1460243
DR Cosmic; 1479523
DR LINCS; 51086
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=15677628;
RX PubMed=23601657;
RX PubMed=25485619;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 13.3,14.3
ST D19S433: 12,14
ST D21S11: 28,31.2
ST D2S1338: 20
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 14,16
ST FGA: 29
ST Penta D: 8,9
ST Penta E: 11
ST TH01: 9.3
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM44PE
AC CVCL_3424
SY SUM-44PE; SUM 44PE; SUM-44 PE; SUM-44; SUM 44; SUM44; Sum44; 44PE
DR BTO; BTO:0005389
DR EFO; EFO_0001245
DR Cosmic; 997937
DR Cosmic; 1289408
DR Cosmic; 1460237
DR GEO; GSM115108
DR GEO; GSM217603
DR GEO; GSM320179
DR GEO; GSM350531
DR GEO; GSM481300
DR GEO; GSM847438
DR GEO; GSM847505
DR GEO; GSM1226542
DR GEO; GSM1226543
DR GEO; GSM1226544
DR GEO; GSM1226545
DR GEO; GSM1226546
DR GEO; GSM1226547
DR GEO; GSM1226548
DR GEO; GSM1226549
DR GEO; GSM1226550
DR GEO; GSM1226551
DR GEO; GSM1226552
DR GEO; GSM1226553
DR GEO; GSM1226554
DR GEO; GSM1226555
DR GEO; GSM1226556
DR GEO; GSM1226557
DR GEO; GSM1226558
DR GEO; GSM1226559
DR GEO; GSM1226560
DR GEO; GSM1226561
DR GEO; GSM1661990
RX PubMed=8425198;
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=12353263;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=23601657;
RX PubMed=24425047;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Omics: CNV analysis.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C7950; Invasive lobular breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUM52PE
AC CVCL_3425
SY SUM-52PE; SUM 52PE; SUM-52-PE; SUM-52; SUM 52; SUM52; 52PE
DR BTO; BTO:0005390
DR EFO; EFO_0001246
DR BioSample; SAMN03472911
DR Cosmic; 904387
DR Cosmic; 1046962
DR Cosmic; 1176647
DR Cosmic; 1287897
DR Cosmic; 1289409
DR Cosmic; 1460238
DR GEO; GSM115109
DR GEO; GSM217604
DR GEO; GSM320178
DR GEO; GSM350524
DR GEO; GSM481330
DR GEO; GSM847439
DR GEO; GSM847506
DR GEO; GSM844711
DR GEO; GSM844712
DR GEO; GSM1374912
DR LINCS; 51087
RX PubMed=10424408;
RX PubMed=10604729;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=23601657;
RX PubMed=25485619;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/SUM52.html
WW http://www.cells-talk.com/index.php/page/copelibrary?key=SUM-52PE
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Omics: CNV analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 10
ST D18S51: 16
ST D21S11: 27,28
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 14
ST D8S1179: 13
ST FGA: 21
ST Penta D: 9,12
ST Penta E: 13,17
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUNE1
AC CVCL_6946
SY SUNE-1; SUNE 1
DR Cosmic; 755507
DR Cosmic; 1193458
DR Cosmic; 1322950
DR Cosmic; 2366882
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SUNE2
AC CVCL_6956
SY SUNE-2
RX PubMed=22176775;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-B1
AC CVCL_A309
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SUP-B12
AC CVCL_A319
RX PubMed=2541219;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-B13
AC CVCL_A308
SY SUPB13
DR Cosmic; 2348805
RX PubMed=1967982;
RX PubMed=3162827;
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0103 ! SUP-B15
SX Male
CA Cancer cell line
//
ID SUP-B15
AC CVCL_0103
SY Sup-B15; SUPB-15; SUPB15; SupB15; SupB15W; SupB15WT
DR CLO; CLO_0009161
DR EFO; EFO_0006763
DR ATCC; CRL-1929
DR BCRJ; 0229
DR BioSample; SAMN03473114
DR CCLE; SUPB15_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1012120
DR Cosmic; 1130245
DR Cosmic; 1498420
DR Cosmic; 1524821
DR Cosmic; 1630017
DR Cosmic; 2491077
DR Cosmic-CLP; 1247871
DR DSMZ; ACC-389
DR GDSC; 1247871
DR GEO; GSM236806
DR GEO; GSM236842
DR GEO; GSM887658
DR GEO; GSM888750
DR GEO; GSM1374913
DR GEO; GSM1670490
DR IZSLER; BS TCL 238
DR PRIDE; PXD000394
RX PubMed=3162827;
RX PubMed=8704231;
RX PubMed=9067587;
RX PubMed=9108419;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25576301;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: HLA class I peptidome analysis by proteomics.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,14
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 28,31
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 19,20
ST Penta D: 9,12
ST Penta E: 21
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A308 ! SUP-B13
SX Male
CA Cancer cell line
//
ID SUP-B15/RI
AC CVCL_S642
SY SUP-B15-RI
DR Cosmic; 1630018
RX PubMed=22285507;
RX PubMed=23230732;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0103 ! SUP-B15
SX Male
CA Cancer cell line
//
ID SUP-B16
AC CVCL_A310
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A321 ! SUP-B19
SX Female
CA Cancer cell line
//
ID SUP-B17
AC CVCL_A322
RX PubMed=2541219;
RX PubMed=8231254;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-B19
AC CVCL_A321
AS CVCL_A311
RX PubMed=8231254;
RX PubMed=8704231;
CC Misspelling: 'SUP-B18' in PubMed=8704231.
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A310 ! SUP-B16
SX Female
CA Cancer cell line
//
ID SUP-B2
AC CVCL_A312
RX PubMed=2875799;
RX PubMed=8231254;
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-B24
AC CVCL_A313
RX PubMed=8231254;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A317 ! SUP-B31
SX Female
CA Cancer cell line
//
ID SUP-B26
AC CVCL_A314
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A316 ! SUP-B28
SX Male
CA Cancer cell line
//
ID SUP-B27
AC CVCL_A315
DR Cosmic; 2396140
DR Cosmic; 2491078
RX PubMed=1967982;
RX PubMed=8231254;
RX PubMed=8704231;
RX PubMed=9067587;
RX PubMed=10490826;
DI NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-B28
AC CVCL_A316
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A314 ! SUP-B26
SX Male
CA Cancer cell line
//
ID SUP-B31
AC CVCL_A317
RX PubMed=8231254;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A313 ! SUP-B24
SX Female
CA Cancer cell line
//
ID SUP-B6
AC CVCL_A320
RX PubMed=2875799;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SUP-B7
AC CVCL_A318
RX PubMed=3469019;
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-B8
AC CVCL_1713
SY SupB8
DR Cosmic; 910209
DR Cosmic-CLP; 910209
DR GDSC; 910209
DR GEO; GSM1670491
RX PubMed=2541219;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-HD1
AC CVCL_2208
SY Sup-HD1; SUP-HD-1; SUPHD1
DR BioSample; SAMN03473483
DR CCLE; SUPHD1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1086360
DR Cosmic; 1278831
DR Cosmic; 1432043
DR Cosmic-CLP; 1331039
DR DSMZ; ACC-574
DR GDSC; 1331039
DR GEO; GSM552469
DR GEO; GSM887659
DR GEO; GSM888751
DR GEO; GSM1670492
RX PubMed=2554995;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-80 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 10,12 (Cosmic-CLP)
ST D7S820: 10,11,12 (DSMZ)
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-M2
AC CVCL_2209
SY SUPM2
DR BTO; BTO:0004775
DR BioSample; SAMN03473512
DR CCLE; SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1086004
DR Cosmic; 1152615
DR Cosmic; 1995648
DR Cosmic-CLP; 1331040
DR DSMZ; ACC-509
DR GDSC; 1331040
DR GEO; GSM887660
DR GEO; GSM888752
DR GEO; GSM1670493
RX PubMed=2525056;
RX PubMed=15356658;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-M2-CR03
AC CVCL_V405
SY SUPM2CR03
DR Cosmic; 1849570
RX PubMed=23239810;
CC Selected for resistance to: ChEBI; CHEBI:64310; Crizotinib (Xalkori).
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2209 ! SUP-M2
SX Female
CA Cancer cell line
//
ID Sup-M2-TS
AC CVCL_B228
SY Sup-M2TS; TS
DR BTO; BTO:0004867
DR GEO; GSM1217149
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2209 ! SUP-M2
SX Female
CA Cancer cell line
//
ID SUP-T1
AC CVCL_1714
SY Sup-T1; SUPT-1; SupT-1; Sup T-1; SUP T-1; SUP T1; Sup T1; SupT1; SUPT1; Tsup-1; VB; Stanford University Pediatric T-cell line 1
DR BTO; BTO:0003582
DR CLO; CLO_0009164
DR CLDB; cl4420
DR CLDB; cl4421
DR CLDB; cl4422
DR ATCC; CRL-1942
DR BCRC; 60191
DR BioSample; SAMN03471266
DR BioSample; SAMN03473416
DR CCLE; SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308368
DR ChEMBL-Targets; CHEMBL614940
DR Cosmic; 687855
DR Cosmic; 909743
DR Cosmic; 1086322
DR Cosmic; 1281384
DR Cosmic; 1330493
DR Cosmic; 1524822
DR Cosmic; 1664528
DR Cosmic; 1760532
DR Cosmic; 2165716
DR Cosmic-CLP; 909743
DR DSMZ; ACC-140
DR ECACC; 95013123
DR GDSC; 909743
DR GEO; GSM482493
DR GEO; GSM887662
DR GEO; GSM888754
DR GEO; GSM1670494
DR ICLC; HTL96007
DR NIH-ARP; 100-322
DR NIH-ARP; 150-147
RX PubMed=3004618;
RX PubMed=3010463;
RX PubMed=3036367;
RX PubMed=3107838;
RX PubMed=3935328;
RX PubMed=6437672;
RX PubMed=6438800;
RX PubMed=7849311;
RX PubMed=9933131;
RX PubMed=22460905;
RX PubMed=22675565;
RX PubMed=25355872;
RX PubMed=27397505;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0024&theme=default
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: Useful in studies of cell fusion and cytopathic effects of HIV-1 as well as cytopathic isolates of HIV-2.
CC Characteristics: Has chromosomal translocations involving the genes for the alpha and beta subunits of TCR thus preventing surface expression of the endogenous TCR complex.
CC Doubling time: ~30 hours (DSMZ); ~24-36 hours (NIH-ARP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; Cosmic-CLP; DSMZ
ST Amelogenin: X,Y (ATCC; Cosmic-CLP)
ST Amelogenin: X (DSMZ)
ST CSF1PO: 10,11
ST D13S317: 11,12 (ATCC; Cosmic-CLP)
ST D13S317: 10,11,12 (DSMZ)
ST D16S539: 9,11,12 (ATCC; Cosmic-CLP)
ST D16S539: 9,10,11 (DSMZ)
ST D5S818: 11,12 (ATCC; Cosmic-CLP)
ST D5S818: 10,11,12 (DSMZ)
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 9 (ATCC; Cosmic-CLP)
ST TPOX: 8,9 (DSMZ)
ST vWA: 16,18 (ATCC; Cosmic-CLP)
ST vWA: 16,18,19 (DSMZ)
DI NCIt; C7210; Childhood T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Sup-T1-CCR5
AC CVCL_X633
SY SupT1/CCR5
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C7210; Childhood T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1714 ! SUP-T1
SX Male
CA Cancer cell line
//
ID Sup-T1/JI
AC CVCL_M773
SY SUP-T1/JI
DR NIH-ARP; 12184-411
DI NCIt; C7210; Childhood T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1714 ! SUP-T1
SX Male
CA Cancer cell line
//
ID SUP-T1/Z29
AC CVCL_M772
SY SUPT-1 / Z29
DR NIH-ARP; 12183-349
RX PubMed=11689646;
DI NCIt; C7210; Childhood T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1714 ! SUP-T1
SX Male
CA Cancer cell line
//
ID SUP-T10
AC CVCL_F689
SY Stanford University Pediatric T-cell line 10
RX PubMed=2786436;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T11
AC CVCL_2210
SY SupT11; SUPT-11; Stanford University Pediatric T-cell line 11
DR BioSample; SAMN03473500
DR CCLE; SUPT11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 913418
DR Cosmic; 1115599
DR Cosmic; 1151792
DR Cosmic; 1524823
DR DSMZ; ACC-605
DR GEO; GSM887661
DR GEO; GSM888753
RX PubMed=2786436;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~35-45 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 11,13
ST D5S818: 13
ST D7S820: 9,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T12
AC CVCL_F691
SY Stanford University Pediatric T-cell line 12
RX PubMed=2786436;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T13
AC CVCL_9973
SY Sup-T13; SupT13; SUPT13; SUPT-13; Stanford University Pediatric T-cell line 13
DR Cosmic; 913417
DR Cosmic; 1115600
DR Cosmic; 1151793
DR Cosmic; 1760533
DR Cosmic; 2165709
RX PubMed=1720549;
RX PubMed=2786436;
RX PubMed=22675565;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-T14
AC CVCL_F692
SY Stanford University Pediatric T-cell line 14
RX PubMed=2786436;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T19
AC CVCL_9974
SY Sup-T19; SUPT19; SupT19; Stanford University Pediatric T-cell line 19
RX PubMed=1720549;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SUP-T2
AC CVCL_F693
SY Stanford University Pediatric T-cell line 2
RX PubMed=3004618;
RX PubMed=6437672;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-T3
AC CVCL_F694
SY Stanford University Pediatric T-cell line 3
RX PubMed=3004618;
RX PubMed=6437672;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T4
AC CVCL_F695
SY Stanford University Pediatric T-cell line 4
RX PubMed=3004618;
RX PubMed=6437672;
RX PubMed=6438800;
DI NCIt; C7226; Adult T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T5
AC CVCL_F686
SY Stanford University Pediatric T-cell line 5
RX PubMed=2786436;
DI NCIt; C9360; Lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T6
AC CVCL_F687
SY Stanford University Pediatric T-cell line 6
RX PubMed=2786436;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T7
AC CVCL_A449
SY SUPT7; SupT7; Stanford University Pediatric T-cell line 7
DR Cosmic; 1115595
DR Cosmic; 1151794
DR Cosmic; 2396143
RX PubMed=1967982;
RX PubMed=2786436;
RX PubMed=3162254;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUP-T8
AC CVCL_F685
SY Stanford University Pediatric T-cell line 8
RX PubMed=2786436;
RX PubMed=2875799;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SUP-T9
AC CVCL_F688
SY Stanford University Pediatric T-cell line 9
RX PubMed=2786436;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SupB15RT
AC CVCL_DR65
DR PRIDE; PXD000394
RX PubMed=25576301;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
CC Omics: HLA class I peptidome analysis by proteomics.
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0103 ! SUP-B15
SX Male
CA Cancer cell line
//
ID Super Dome
AC CVCL_6452
SY MDCK superdome
DR ATCC; CRL-2286
DR CCRID; 3111C0001CCC000225
RX PubMed=21982418;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID Super Tube
AC CVCL_6453
SY MDCK supertube
DR ATCC; CRL-2285
RX PubMed=21982418;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID Super-CHO C1
AC CVCL_IR03
SY Super-CHO clone C1; CHO-IGF/Tf C1
RX Patent=US6797515;
RX PubMed=22358924;
CC Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.
CC Doubling time: 18 hours (PubMed=19003411).
CC Transfected with: HGNC; 5464; IGF1.
CC Transfected with: HGNC; 11740; TF.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Super-CHO C2
AC CVCL_IR04
SY Super-CHO clone C2; CHO-IGF/Tf C2
RX Patent=US6797515;
RX PubMed=22358924;
CC Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.
CC Doubling time: 21 hours (PubMed=19003411).
CC Transfected with: HGNC; 5464; IGF1.
CC Transfected with: HGNC; 11740; TF.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Super-CHO C2.8
AC CVCL_IR05
SY Super-CHO clone C2.8; C2.8
RX PubMed=19003411;
RX DOI=10.1002/jctb.1670;
CC Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.
CC Transfected with: HGNC; 5464; IGF1.
CC Transfected with: HGNC; 11740; TF.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_IR04 ! Super-CHO C2
SX Female
CA Spontaneously immortalized cell line
//
ID Super-CHO ISS9
AC CVCL_IR06
SY Super-CHO clone ISS9; ISS9
RX PubMed=19003411;
CC Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.
CC Transfected with: HGNC; 5464; IGF1.
CC Transfected with: HGNC; 11740; TF.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID SURE CHO-M
AC CVCL_R728
SY CHO-M; CHOM
WW http://www.selexis.com/#!sure-cho-m-cell-line/ctak
WW http://www.selexis.com/#!sure-cho-m-genome/c1gti
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID SuSa
AC CVCL_L280
SY SUSA
DR DSMZ; ACC-747
DR GEO; GSM863899
RX PubMed=593370;
RX PubMed=6169654;
CC Doubling time: ~48-72 hours (DSMZ).
ST Source(s): DSMZ; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12,14
ST D21S11: 29
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 15
ST FGA: 21,21.2
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SUSM-1
AC CVCL_4903
SY SUSM1
DR CLO; CLO_0050043
DR BioSample; SAMN03472342
DR RCB; RCB0174
RX PubMed=3413074;
RX PubMed=8105370;
RX PubMed=8148305;
RX PubMed=8557247;
RX PubMed=9175740;
RX PubMed=9290701;
CC Transformant: ChEBI; CHEBI:16907; 4-nitroquinoline N-oxide (4NQO).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M811 ! AD387
SX Male
CA Transformed cell line
//
ID SV
AC CVCL_E938
DR JCRB; JCRB1207
RX PubMed=27844419;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID SV-3Y1-C66
AC CVCL_F822
SY SV-3Y1
DR JCRB; JCRB0735
DR RCB; RCB0343
RX PubMed=2961438;
RX PubMed=3533570;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID SV-A3
AC CVCL_0540
DR MCCL; MCC:0000441
RX PubMed=11387343;
CC Transformant: Ad-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SV-AL/N
AC CVCL_L813
SY SVS AL/N
RX PubMed=174816;
RX PubMed=4302577;
RX PubMed=4331720;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: AL/N.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6312 ! AL/N
CA Transformed cell line
//
ID SV-BR-1
AC CVCL_4U12
SY SV-BR1
DR ATCC; PTA-7812
RX Patent=US7674456;
RX PubMed=16958969;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SV-BR-1-GM
AC CVCL_4U13
SY SVBR-1-GM
DR ATCC; PTA-7813
RX Patent=US7674456;
RX PubMed=16958969;
CC Transfected with: HGNC; 2434; CSF2.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4U12 ! SV-BR-1
SX Female
CA Cancer cell line
- 公告/新闻
